Tenders/ADCM 4691/25 - Metoxsaleno 0,02 mg/ml Sol Inj 10 ml ( UVADEX)
Awarded🇵🇹PortugalSupplies

ADCM 4691/25 - Metoxsaleno 0,02 mg/ml Sol Inj 10 ml ( UVADEX)

Instituto Português de Oncologia do Porto Francisco Gentil, EPE
Published: Feb 11, 2026
Updated: Jun 20, 2026
Source: Portal BASE (Portugal)

About This Opportunity

Portugal contract award (healthcare): ADCM 4691/25 - Metoxsaleno. By Instituto Português de Oncologia do Porto Francisco. Awarded to CLINIGEN IRELAND LIMITED.

This is a supplies contract in the health and medical services, Monitoring Evaluation and general supplies sectors, with a focus on Pharmaceuticals. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 1.7 million – EUR 2,377.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

The tender ADCM 4691/25 pertains to the procurement of Metoxsaleno, specifically a solution for injection at a concentration of 0.02 mg/ml, packaged in 10 ml vials, commonly referred to as UVADEX. This tender is issued within the context of pharmaceutical supplies required for healthcare services in Portugal. The contracting authority, while not explicitly stated, typically involves healthcare institutions or public health agencies that operate under the auspices of the Portuguese government.

In the pharmaceutical procurement domain, typical requirements include compliance with regulatory standards, quality assurance protocols, and delivery timelines. Bidders are expected to demonstrate their capability to supply high-quality products that meet the necessary health and safety regulations established by relevant Portuguese and European health authorities. Additionally, suppliers may need to provide documentation that affirms product efficacy and safety, as well as any certifications or licenses required for the distribution of pharmaceutical products.

Given the critical nature of healthcare supply chains, timely delivery and reliability of the product are paramount considerations in the evaluation process. Potential bidders should be prepared to furnish evidence of past performance in similar contracts, capacity for bulk production, and logistical arrangements to ensure consistent supply. This tender presents an opportunity for qualified suppliers to engage with public health procurement in Portugal, contributing to the healthcare system's ability to provide essential medical treatments to patients.

Data provenance

This notice is sourced from base_gov_pt and was originally published on February 11, 2026. Last refreshed 5 days ago. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Instituto Português de Oncologia do Porto Francisco Gentil, EPE

Instituto Português de Oncologia do Porto Francisco Gentil, EPE has issued 4,054 procurement notices on BidsFactory, including 0 currently open and 3,989 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Governance & Public Administration. All notices are published for Portugal. Notices are distributed via base_gov_pt and TED - Tenders Electronic Daily (EU). Most recent publication: June 18, 2026.

Frequently asked questions about this tender

How can I submit a bid?

Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.

Is this tender still open?

No — the contract has already been awarded to CLINIGEN IRELAND LIMITED. The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by Instituto Português de Oncologia do Porto Francisco Gentil, EPE in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

What is the estimated budget?

The estimated contract value is €1,686,725 - €2,377. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.

Where will the contract be performed?

The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

Find tenders like this automatically

Set up alerts and filters that match your business — never miss a relevant opportunity again.

See plans

Key Details

Estimated Budget
€1,686,725 - €2,377
Contract Type
Supplies
Eligibility
Firms / Consortiums
Language
English

Contracting Authority

Instituto Português de Oncologia do Porto Francisco Gentil, EPE
🇵🇹Portugal

Matching Experts

Are you a consultant?

Join our Expert Network and get matched with relevant tenders.